Application 200533
- Type
- NDA
- Sponsor
- COLLEGIUM PHARM INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NUCYNTA ER | TAPENTADOL HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 50MG BASE | Yes | No |
| 002 | NUCYNTA ER | TAPENTADOL HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 100MG BASE | Yes | No |
| 003 | NUCYNTA ER | TAPENTADOL HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 150MG BASE | Yes | No |
| 004 | NUCYNTA ER | TAPENTADOL HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 200MG BASE | Yes | No |
| 005 | NUCYNTA ER | TAPENTADOL HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | EQ 250MG BASE | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N200533-001 | NUCYNTA ER | TAPENTADOL HYDROCHLORIDE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | |
| N200533-002 | NUCYNTA ER | TAPENTADOL HYDROCHLORIDE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | |
| N200533-003 | NUCYNTA ER | TAPENTADOL HYDROCHLORIDE | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | |
| N200533-004 | NUCYNTA ER | TAPENTADOL HYDROCHLORIDE | EQ 200MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | |
| N200533-005 | NUCYNTA ER | TAPENTADOL HYDROCHLORIDE | EQ 250MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-08-25 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N200533-001 | 11344512 | 2028-04-21 | U-3391 | 2022-06-29 | |
| N200533-001 | 11344512 | 2028-04-21 | U-3392 | 2022-06-29 | |
| N200533-001 | 8536130 | 2028-09-22 | U-1276 | ||
| N200533-001 | 11344512*PED | 2028-10-21 | Pediatric extension | ||
| N200533-001 | 8536130*PED | 2029-03-22 | Pediatric extension | ||
| N200533-002 | 11344512 | 2028-04-21 | U-3391 | 2022-06-29 | |
| N200533-002 | 11344512 | 2028-04-21 | U-3392 | 2022-06-29 | |
| N200533-002 | 8536130 | 2028-09-22 | U-1276 | ||
| N200533-002 | 11344512*PED | 2028-10-21 | Pediatric extension | ||
| N200533-002 | 8536130*PED | 2029-03-22 | Pediatric extension | ||
| N200533-003 | 11344512 | 2028-04-21 | U-3391 | 2022-06-29 | |
| N200533-003 | 11344512 | 2028-04-21 | U-3392 | 2022-06-29 | |
| N200533-003 | 8536130 | 2028-09-22 | U-1276 | ||
| N200533-003 | 11344512*PED | 2028-10-21 | Pediatric extension | ||
| N200533-003 | 8536130*PED | 2029-03-22 | Pediatric extension | ||
| N200533-004 | 11344512 | 2028-04-21 | U-3391 | 2022-06-29 | |
| N200533-004 | 11344512 | 2028-04-21 | U-3392 | 2022-06-29 | |
| N200533-004 | 8536130 | 2028-09-22 | U-1276 | ||
| N200533-004 | 11344512*PED | 2028-10-21 | Pediatric extension | ||
| N200533-004 | 8536130*PED | 2029-03-22 | Pediatric extension | ||
| N200533-005 | 11344512 | 2028-04-21 | U-3391 | 2022-06-29 | |
| N200533-005 | 11344512 | 2028-04-21 | U-3392 | 2022-06-29 | |
| N200533-005 | 8536130 | 2028-09-22 | U-1276 | ||
| N200533-005 | 11344512*PED | 2028-10-21 | Pediatric extension | ||
| N200533-005 | 8536130*PED | 2029-03-22 | Pediatric extension |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N200533-001 | NUCYNTA ER | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200533-002 | NUCYNTA ER | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200533-003 | NUCYNTA ER | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200533-004 | NUCYNTA ER | EQ 200MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200533-005 | NUCYNTA ER | EQ 250MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-08-25 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-001 | NUCYNTA ER | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-002 | NUCYNTA ER | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-003 | NUCYNTA ER | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-004 | NUCYNTA ER | EQ 200MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-005 | NUCYNTA ER | EQ 250MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-08-25 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N200533-001 | NUCYNTA ER | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N200533-002 | NUCYNTA ER | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N200533-003 | NUCYNTA ER | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N200533-004 | NUCYNTA ER | EQ 200MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N200533-005 | NUCYNTA ER | EQ 250MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-08-25 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N200533-001 | NUCYNTA ER | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N200533-002 | NUCYNTA ER | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N200533-003 | NUCYNTA ER | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N200533-004 | NUCYNTA ER | EQ 200MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N200533-005 | NUCYNTA ER | EQ 250MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-08-25 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N200533-001 | NUCYNTA ER | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N200533-002 | NUCYNTA ER | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N200533-003 | NUCYNTA ER | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N200533-004 | NUCYNTA ER | EQ 200MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N200533-005 | NUCYNTA ER | EQ 250MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-08-25 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N200533-001 | NUCYNTA ER | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N200533-002 | NUCYNTA ER | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N200533-003 | NUCYNTA ER | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N200533-004 | NUCYNTA ER | EQ 200MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N200533-005 | NUCYNTA ER | EQ 250MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-08-25 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N200533-001 | NUCYNTA ER | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N200533-002 | NUCYNTA ER | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N200533-003 | NUCYNTA ER | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N200533-004 | NUCYNTA ER | EQ 200MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N200533-005 | NUCYNTA ER | EQ 250MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-08-25 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N200533-001 | NUCYNTA ER | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N200533-002 | NUCYNTA ER | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N200533-003 | NUCYNTA ER | EQ 150MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N200533-004 | NUCYNTA ER | EQ 200MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-08-25 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N200533-005 | NUCYNTA ER | EQ 250MG BASE | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-08-25 | 5bbf6a4d5a75… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N200533-001 | 11344512 | 2028-04-21 | U-3391 | 2022-06-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200533-001 | 11344512 | 2028-04-21 | U-3392 | 2022-06-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200533-001 | 8536130 | 2028-09-22 | U-1276 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N200533-001 | 11344512*PED | 2028-10-21 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N200533-001 | 8536130*PED | 2029-03-22 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N200533-002 | 11344512 | 2028-04-21 | U-3392 | 2022-06-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200533-002 | 11344512 | 2028-04-21 | U-3391 | 2022-06-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200533-002 | 8536130 | 2028-09-22 | U-1276 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N200533-002 | 11344512*PED | 2028-10-21 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N200533-002 | 8536130*PED | 2029-03-22 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N200533-003 | 11344512 | 2028-04-21 | U-3392 | 2022-06-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200533-003 | 11344512 | 2028-04-21 | U-3391 | 2022-06-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200533-003 | 8536130 | 2028-09-22 | U-1276 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N200533-003 | 11344512*PED | 2028-10-21 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N200533-003 | 8536130*PED | 2029-03-22 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N200533-004 | 11344512 | 2028-04-21 | U-3392 | 2022-06-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200533-004 | 11344512 | 2028-04-21 | U-3391 | 2022-06-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200533-004 | 8536130 | 2028-09-22 | U-1276 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N200533-004 | 11344512*PED | 2028-10-21 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N200533-004 | 8536130*PED | 2029-03-22 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N200533-005 | 11344512 | 2028-04-21 | U-3392 | 2022-06-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200533-005 | 11344512 | 2028-04-21 | U-3391 | 2022-06-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N200533-005 | 8536130 | 2028-09-22 | U-1276 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N200533-005 | 11344512*PED | 2028-10-21 | Pediatric extension | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N200533-005 | 8536130*PED | 2029-03-22 | Pediatric extension | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-001 | 7994364 | 2025-06-27 | U-1276 | Drug substance, Drug product | 2011-09-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-001 | 7994364 | 2025-06-27 | U-1178 | Drug substance, Drug product | 2011-09-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-001 | 7994364*PED | 2025-12-27 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-001 | 11344512 | 2028-04-21 | U-3391 | 2022-06-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-001 | 11344512 | 2028-04-21 | U-3392 | 2022-06-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-001 | 8536130 | 2028-09-22 | U-1276 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-001 | 11344512*PED | 2028-10-21 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-001 | 8536130*PED | 2029-03-22 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-002 | 7994364 | 2025-06-27 | U-1178 | Drug substance, Drug product | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-002 | 7994364 | 2025-06-27 | U-1276 | Drug substance, Drug product | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-002 | 7994364*PED | 2025-12-27 | Pediatric extension | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-002 | 11344512 | 2028-04-21 | U-3392 | 2022-06-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-002 | 11344512 | 2028-04-21 | U-3391 | 2022-06-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-002 | 8536130 | 2028-09-22 | U-1276 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N200533-002 | 11344512*PED | 2028-10-21 | Pediatric extension | 31067a03dcf5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TAPENTADOL | TAPENTADOL HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 38de863e-56ff-4c43-9ab8-9b3e1ba82858 | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | 200533 NDA200533 |
| Nucynta ER | TAPENTADOL HYDROCHLORIDE | Collegium Pharmaceutical, Inc. | c3d04d70-0155-4147-9ce4-a3b1fad4b373 | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | 200533 NDA200533 24510-116 24510-291 24510-058 24510-174 24510-232 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 24510-058 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-058 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-058 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-058 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-058 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-116 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-116 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-116 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-116 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-116 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-174 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-174 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-174 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-174 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-174 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-232 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-232 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-232 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-232 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-232 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-291 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-291 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-291 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-291 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 24510-291 | Nucynta | tapentadol hydrochloride | Collegium Pharmaceutical, Inc. | NDA | Current |
| 50458-860 | Nucynta | tapentadol hydrochloride | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-861 | Nucynta | tapentadol hydrochloride | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-862 | Nucynta | tapentadol hydrochloride | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-863 | Nucynta | tapentadol hydrochloride | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 50458-864 | Nucynta | tapentadol hydrochloride | Janssen Pharmaceuticals, Inc. | NDA | Current |
| 55700-555 | Nucynta | tapentadol hydrochloride | LAKE ERIE MEDICAL DBA QUA | NDA | Current |
| 55700-555 | Nucynta | tapentadol hydrochloride | LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC | NDA | Current |
| 55700-565 | Nucynta | tapentadol hydrochloride | Lake Erie Medical DBA Quality Care Products LLC | NDA | Current |
| 55700-796 | Nucynta | tapentadol hydrochloride | Quality Care Products, LLC | NDA | Current |
| 55700-796 | Nucynta | tapentadol hydrochloride | Quality Care Products, LLC | NDA | Current |
| 55700-796 | Nucynta | tapentadol hydrochloride | Quality Care Products, LLC | NDA | Current |
| 55700-797 | Nucynta | tapentadol hydrochloride | Quality Care Products, LLC | NDA | Current |
| 55700-797 | Nucynta | tapentadol hydrochloride | Quality Care Products, LLC | NDA | Current |
| 55700-797 | Nucynta | tapentadol hydrochloride | Quality Care Products, LLC | NDA | Current |
| 69865-240 | Nucynta | tapentadol hydrochloride | Depo NF Sub, LLC | NDA | Current |
| 69865-245 | Nucynta | tapentadol hydrochloride | Depo NF Sub, LLC | NDA | Current |
| 69865-250 | Nucynta | tapentadol hydrochloride | Depo NF Sub, LLC | NDA | Current |
| 69865-260 | Nucynta | tapentadol hydrochloride | Depo NF Sub, LLC | NDA | Current |
| 69865-265 | Nucynta | tapentadol hydrochloride | Depo NF Sub, LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 84534 | SUPPL | 2025-12-23 |
| 84525 | SUPPL | 2025-12-23 |
| 80079 | SUPPL | 2024-11-04 |
| 80078 | SUPPL | 2024-11-04 |
| 78823 | SUPPL | 2024-06-18 |
| 78822 | SUPPL | 2024-06-18 |
| 78813 | SUPPL | 2024-06-18 |
| 77070 | SUPPL | 2023-12-19 |
| 76943 | SUPPL | 2023-12-18 |
| 66627 | SUPPL | 2021-03-08 |
| 66626 | SUPPL | 2021-03-08 |
| 66570 | SUPPL | 2021-03-08 |
| 60393 | SUPPL | 2019-10-08 |
| 60392 | SUPPL | 2019-10-08 |
| 60378 | SUPPL | 2019-10-08 |
| 55693 | SUPPL | 2018-10-01 |
| 55692 | SUPPL | 2018-10-01 |
| 55590 | SUPPL | 2018-09-24 |
| 55589 | SUPPL | 2018-09-24 |
| 48583 | SUPPL | 2017-05-31 |
| 46411 | SUPPL | 2016-12-21 |
| 46328 | SUPPL | 2016-12-20 |
| 45456 | SUPPL | 2016-10-03 |
| 9827 | SUPPL | 2016-04-22 |
| 32030 | SUPPL | 2015-07-07 |
| 32029 | SUPPL | 2014-08-20 |
| 32028 | SUPPL | 2014-04-17 |
| 40024 | SUPPL | 2014-04-16 |
| 32027 | SUPPL | 2013-04-18 |
| 40023 | SUPPL | 2012-08-29 |
| 32025 | SUPPL | 2012-08-29 |
| 18962 | SUPPL | 2012-07-12 |
| 32026 | SUPPL | 2012-07-11 |
| 43346 | ORIG | 2012-04-12 |
| 24095 | ORIG | 2011-08-30 |
| 32024 | ORIG | 2011-08-29 |
| 18961 | ORIG | 2011-08-26 |